Table 2.
Measured variables
| Mean ± SD | Sample N | |
|---|---|---|
| Normally distributed variables | ||
| Systolic Blood Pressure, mm Hg | 95.59 ± 10.53 | 131 |
| Diastolic Blood Pressure, mm Hg | 59.70 ± 8.21 | 131 |
| Systolic Blood Pressure, % | 59.77 ± 27.98 | 131 |
| Diastolic Blood Pressure, % | 74.83 ± 20.00 | 131 |
| Total Cholesterol, mg/dL | 146.46 ± 26.82 | 139 |
| Low Density Lipoprotein, mg/dL | 84.35 ± 23.58 | 139 |
| High Density Lipoprotein, mg/dL, | 48.73 ± 13.28 | 139 |
| Fasting blood glucose, mg/dl | 80.68 ± 7.28 | 139 |
| Total anti-oxidant capacity, mm Trolox equivalent | 102.59 ± 22.65 | 138 |
| Soluble ICAM-1, ng/mL | 206.89 ± 64.96 | 138 |
| Median (IQR) | ||
| Skewed distribution variables | ||
| Fasting insulin, uIU/mL | 6.46 (5.33–8.33) | 138 |
| C-Reactive Protein, mg/L | 0.22 (0.04–1.27) | 138 |
| Interleukin-6, ng/L | 13.31 (4.69–113.70) | 138 |
| TNF-α, ng/L | 148.66 (76.54–1026.86) | 138 |
| Plasma protein malondialdehyde, pmol MDA/mL | 18.8 (15.1–22.8) | 138 |
| Circulating CD34+ Cells, % of total events | 0.0086 (0.0042–0.0156) | 122 |